An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

NCT07020819 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Guillain-Barre Syndrome

Interventions

DRUG: Tanruprubart

Sponsor

Annexon, Inc.